Piramal Pharma Limited at its board meeting held on May 10, 2024, recommended a final dividend of INR 0.11 per Equity Share of INR 10 each for the financial year ended 31 March 2024, which will be paid /dispatched after the 4th Annual General Meeting, subject to the approval of shareholders of the Company. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed 12th July, 2024 as the Record Date for the purpose of determining the Members eligible for Final Dividend for the financial year ended 31st March, 2024. If the Final Dividend as recommended by the Board of Directors is approved at the AGM, such dividend will be paid/dispatched, subject to deduction of tax at source, after the AGM.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156.6 INR | +0.86% |
|
-0.80% | +12.78% |
May. 14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
May. 13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.78% | 2.48B | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Piramal Pharma Limited Recommends Final Dividend for the Financial Year Ended 31 March 2024